RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00034925.xml
PDF herunterladen
Hamostaseologie 1990; 10(01): 32-38
DOI: 10.1055/s-0038-1655178
DOI: 10.1055/s-0038-1655178
Originalarbeiten
Thrombolysetherapie zerebraler Arterienverschlüsse
Autoren
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
25. Juni 2018 (online)
-
LITERATUR
- 1 Abe T, Kazawa M, Naito I. Clinical evaluation for efficiancy of tissue culture urokinase (TCUK) on cerebral thrombosis by means of multicenter double blind study. Blood Vessels 1981; 12: 321-41.
- 2 Abe T, Kazawa M, Naito I. Clinical effect of urokinase (60,000 units/day) on cerebral infarction - comparative study by means of multiple center double blind test. Blood Vessels 1981; 12: 342-58.
- 3 Aldrich M S, Sherman S A, Greenberg H S. Cerebrovascular complications of streptokinase infusion. JAMA 1985; 253: 1777-9.
- 4 Astrup J, Siesjo B K, Symon L. Thresholds in cerebral ischemia - The ischemic penumbra. Stroke 1981; 12: 723-5.
- 5 Brott T, Haley C, Levy D E, Barsan W G, Reed R L, Olinger C P, Marier J R. Very early therapy for cerebral infarction with tPA. Stroke 1988; 19: 8.
- 6 Carlson S E, Aldrich M S, Greenberg H S, Topol E J. Intracerebral hemorrhage complicating intravenous tissue plasminogen activator treatment. Arch Neurol 1988; 45: 1070-3.
- 7 Clarke R L, Cliffton E E. The treatment of cerebrovascular thrombosis and embolism with fibrinolytic agents. Am J Cardiol 1960; 30: 546-51.
- 8 Crabbe S J, Clononger C C. Tissue plasminogen activator: A new thrombolytic agent. Clin Pharm 1987; 06: 373-86.
- 9 Dalai P M. Cerebral embolism. Angiographic observation on spontaneous clot lysis. Lancet 1965; I: 61-4.
- 10 Del Zoppo G J, Copeland B R, Waltz T A. The beneficial effect of intracarotid urokinase on acute stroke in a baboon model. Stroke 1986; 17: 638-43.
- 11 Del Zoppo G J, Ferbert A, Otis S, Briick-mann H, Hacke W, Zyroff J, Harker L A, Zeumer H. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke: A pilot study. Stroke 1988; 19: 307-13.
- 12 Fisher C M. The “Herald Hemiparesis” of the basilar artery occlusion. Arch Neurol 1988; 45: 1301-3.
- 13 Fletcher A P, Alkjaersig N, Lewis M, Tulevski V, Davies A, Brooks J E, Mardin W B, Landau W M, Raichle M E. A pilot study of urokinase therapy in cerebral infarction. Stroke 1976; 07: 135-42.
- 14 Hacke W, Hirschberg M. Experimentelle und erste klinische Erfahrungen mit der Thrombolysetherapie mit rt-PA bei thrombotischen Zerebralarterienverschlüssen. Hämostaseologie 1988; 08: 230-2.
- 15 Hacke W, Zeumer H, Ferbert A, Brtick-mann H, del Zoppo G J. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988; 19: 1216-22.
- 16 Henze T, Tebbe U. Erste Erfahrungen mit Tissue plasminogen Aktivator (tPA) bei der Fibrinolyse von Thrombosen der A. basilaris. Akt Neurol 1989; 16: XXIII
- 17 Herndon R M, Nelson J M, Johnson J F, Meyer J S. Thrombolytic treatment in cerebrovascular thrombosis. In: Anticoagulants and Fibrinolysis. Macmillan R L, Mustard J F. (eds). Philadelphia: Lea & Febiger; 1961: 154-64.
- 18 Hornig C R, Dorndorf W, Agnoli A L. Hemorrhagic infarction - A prospective study. Stroke 1986; 17: 179-85.
- 19 Irino T, Taneda M, Minami T. Angiographic manifestation in postrecanalized cerebral infarction. Neurology 1977; 27: 471-75.
- 20 Jones H R, Clark H M, Sandok B A. Temporal profile (clinical course) of acute vertebrobasilar system cerebral infarction. Stroke 1980; 11: 173-7.
- 21 Jones H R, Millikan C H. Temporal profile (clinical course) of acute carotid system cerebral infarction. Stroke 1976; 07: 64-9.
- 22 Kollikowski H, Ewert T, Lehmann H J, Scharafinski H W, Schulz M. Intraarterielle lokale Fibrinolysetherapie der A. basilaris - Thrombose bei älteren Gefäßpatienten. . Akt Neurol 1986; 13: 201-6.
- 23 Labauge R, Bland J M, Salvaing P. et al. Traitment fibrinolytique et anticoagulant dans 37 cas d’occlusions arterielles: Cervico- cerebrales d’origine thromboembolique. In: Proceedings of the Fifth International Congress on Thromboembolism. Bologna, Italy; 1978. Pisa, Italy, Quaderni della Coagu- lazione, 1980; 362-4.
- 24 Larcan A, Laprevote-Heully M C, Lampert H. et al. Indications des thrombolytiques au cours des accidents vasculaires cérébraux thrombosants traites par ailleurs par OMB (ZATA). Therapie 1977; 32: 259-70.
- 25 Malinovsky N N, Kozlov V A. Embolism of the cerebral arteries. In: Anticoagulant and Thrombolytic Therapy in Surgery. St. Louis; Mosby CV: 1979: 239-50.
- 26 Matsuo O, Kosugi T, Mihara H, Ohki Y, Matsuo T. Retrospective study on the efficiency of using urokinase therapy. Acta Haem Jap 1979; 42: 684-8.
- 27 Meyer J S, Gilroy J, Barnhardt M E, Johnson J F. Therapeutic thrombolysis in cerebral thrombembolism: randomized evaluation of intravenous streptokinase. In: Millikan C H, Siekert R G, Whisnant J P. (eds): Cerebrovascular Diseases, Fourth Princeton Conference. New York: Grune & Stratton; 1965: 200-13.
- 28 Meyer J S, Herndon R M, Gotoh F, Tazaki Y, Nelson J N, Johnson J F. Therapeutic thrombolysis. In: Millikan C H, Siekert R G, Whisnant J P. (eds): Cerebrovascular Diseases, Third Princeton Conference. New York: Grune & Stratton; 1961: 160-77.
- 29 Miyakawa T. The cerebral vessels and thrombosis. Rinsho Ketseuki 1984; 25: 1018-26.
- 30 Mori E, Tabuchi M, Yoshida T, Yamadori A. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 1988; 19: 802-12.
- 31 Nenci G G, Gresele P, Taramelli M, Agnelli G, Signorini E. Thrombolytic therapy for thromboembolism of vertebrobasilar artery. Angiology 1983; 34: 561-71.
- 32 Okada Y, Yamaguchi T, Minematsu K, Miyashita T, Sawada T, Sadoshima S, Fuji-shima M, Omae T. Hemorrhagic transformation in cerebral embolism. Stroke 1989; 20: 598-603.
- 33 Poeck K, Hacke W. Akuter ischämischer cerebraler Insult. Voraussetzungen für die Wirksamkeit aktiver Enzyme. Deutsches Ärzteblatt 1989; 86: 33-4.
- 34 Romatowski H J v, Heinze T h, Tebbe U. Rekanalisation eines Verschlusses der A. basilaris mit Gewebe-Plasminogen-Aktivator. Dtsch Med Wochenschr 1988; 113: 616.
- 35 Rosen F v, Franz P, Einhäupl K. Negative klinische und angiographische Ergebnisse bei Anwendung von TPA zur Thrombolyse von Basilaris- und Sinusvenenthrombosen. Akt Neurol 1989; 16: XXIV
- 36 Slivka A, Pusinelli W. Hemorrhagic complications of thrombolytic therapy in experimental stroke. Stroke 1987; 18: 1148-56.
- 37 The tPA-Acute Stroke Study Group. An open multicenter study on the safety and efficiency of various doses of r-tPA in patients with acute stroke: preliminary results. Stroke 1988; 19: 134.
- 38 Theiss W. Welche Laborparameter sind bei der fibrinolytischen Therapie sinnvoll und notwendig?. Klin Wochenschr 1988; 66 (Suppl XII): 55-8.
- 39 Zeumer H. Vascular recanalizing techniques in interventional neuroradiology. J Neurol 1985; 231: 287-94.
- 40 Zeumer H, Freitag H J, Gryska U, Neunzig H P. Local intraarterial fibrinolysis in acute vertebrobasilar occlusion. Technical developments and recent results. Neuroradiology. 1989 31. (im Druck)
- 41 Zimmermann R, Heuck C C, Havenberg J, Kummer R, Schmidt-Geyk U, Simon B, Wahl P, Mörl H, Weber P G. Fibrinolytische Therapie einer schweren Arteria-basi- laris-Thrombose. Dtsch Med Wochenschr 1981; 106: 464-7.
- 42 Zivin J A, Lyden P D, DeGirolami U. Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke. Arch Neurol 1988; 45: 387-91.